DD13769A - - Google Patents
Info
- Publication number
- DD13769A DD13769A DD13769DA DD13769A DD 13769 A DD13769 A DD 13769A DD 13769D A DD13769D A DD 13769DA DD 13769 A DD13769 A DD 13769A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD13769A true DD13769A (fr) |
Family
ID=225646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD13769D DD13769A (fr) |
Country Status (1)
| Country | Link |
|---|---|
| DD (1) | DD13769A (fr) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104662007B (zh) * | 2012-07-25 | 2018-03-16 | 索瓦制药公司 | 胱硫醚‑γ‑裂合酶(CSE)抑制剂 |
-
0
- DD DD13769D patent/DD13769A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104662007B (zh) * | 2012-07-25 | 2018-03-16 | 索瓦制药公司 | 胱硫醚‑γ‑裂合酶(CSE)抑制剂 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018200632B2 (en) | Cystathionine-y-lyase (CSE) inhibitors | |
| JP2015524807A5 (fr) | ||
| CN106029641B (zh) | 1,1-二取代肼化合物的制造方法 | |
| US11021501B2 (en) | Creatine phosphate analog prodrugs, compositions and methods of use thereof | |
| US9504655B2 (en) | Capsule dosage form of metoprolol succinate | |
| WO2020247819A2 (fr) | Méthode de traitement à l'aide de modulateurs de l'acide aminolévulinique synthase 2 (alas2) | |
| DD207626A3 (de) | Verfahren zur herstellung des 3-amino-5-hydrazino-1,2,4-triazols und dessen derivaten | |
| DD13769A (fr) |